Meindert Boysen

1.3k total citations · 2 hit papers
9 papers, 806 citations indexed

About

Meindert Boysen is a scholar working on Economics and Econometrics, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Meindert Boysen has authored 9 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 3 papers in General Health Professions and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Meindert Boysen's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Healthcare Policy and Management (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Meindert Boysen is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Healthcare Policy and Management (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Meindert Boysen collaborates with scholars based in United Kingdom, United States and Netherlands. Meindert Boysen's co-authors include Kevin Marsh, Maarten J. IJzerman, Rob Baltussen, Filip Mussen, Stuart Peacock, Nancy Devlin, John B. Watkins, Praveen Thokala, Zoltán Kaló and Carole Longson and has published in prestigious journals such as The Lancet Oncology, BMJ and Value in Health.

In The Last Decade

Meindert Boysen

9 papers receiving 793 citations

Hit Papers

Multiple Criteria Decision Analysis for Health Care Decis... 2016 2026 2019 2022 2016 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
    2016 444 citations Praveen Thokala, Nancy Devlin et al. Value in Health profile →
  2. Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
    2016 301 citations Kevin Marsh, Maarten J. IJzerman et al. Value in Health profile →

Peers

Meindert Boysen
Filip Mussen United States
Ruth Davies United Kingdom
John A. Vernon United States
Vakaramoko Diaby United States
Saskia Knies Netherlands
Jui-fen Rachel Lu Taiwan
Hanane Khoury Canada
Donna Rindress Canada
Petra Schnell‐Inderst Austria
Chris Henshall United Kingdom
Filip Mussen United States
Meindert Boysen
Citations per year, relative to Meindert Boysen Meindert Boysen (= 1×) peers Filip Mussen

Countries citing papers authored by Meindert Boysen

Since Specialization
Citations

This map shows the geographic impact of Meindert Boysen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meindert Boysen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meindert Boysen more than expected).

Fields of papers citing papers by Meindert Boysen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meindert Boysen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meindert Boysen. The network helps show where Meindert Boysen may publish in the future.

Co-authorship network of co-authors of Meindert Boysen

This figure shows the co-authorship network connecting the top 25 collaborators of Meindert Boysen. A scholar is included among the top collaborators of Meindert Boysen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meindert Boysen. Meindert Boysen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Boysen, Meindert, Kenneth Bond, Rick A. Vreman, et al.. (2024). An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report. International Journal of Technology Assessment in Health Care. 40(1). e45–e45. 4 indexed citations
2.
Boysen, Meindert, Kenneth Bond, Rick A. Vreman, et al.. (2024). Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report. International Journal of Technology Assessment in Health Care. 40(1). e50–e50. 6 indexed citations
3.
Cooper, Sophie, Jacoline C. Bouvy, Lawrence Baker, et al.. (2020). How should we assess the clinical and cost effectiveness of histology independent cancer drugs?. BMJ. 368. l6435–l6435. 17 indexed citations
4.
Bont, Antoinette de, et al.. (2020). Around the Tables – Contextual Factors in Healthcare Coverage Decisions Across Western Europe. International Journal of Health Policy and Management. 9(9). 390–402. 10 indexed citations
5.
Bouvy, Jacoline C., et al.. (2018). PCP19 - AN UPDATED NICE POSITION ON THE EQ-5D-5L VALUATION SET. Value in Health. 21. S84–S85. 4 indexed citations
6.
Thokala, Praveen, Nancy Devlin, Kevin Marsh, et al.. (2016). Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value in Health. 19(1). 1–13. 444 indexed citations breakdown →
7.
Marsh, Kevin, Maarten J. IJzerman, Praveen Thokala, et al.. (2016). Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value in Health. 19(2). 125–137. 301 indexed citations breakdown →
8.
Chung, Helen, et al.. (2009). Lenalidomide for the treatment of relapsed multiple myeloma. The Lancet Oncology. 10(7). 647–648. 3 indexed citations
9.
Boysen, Meindert, et al.. (2008). Erlotinib for the treatment of non-small-cell lung cancer. The Lancet Oncology. 10(1). 15–16. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Filip Mussen Breakdown of academic impact, for papers by Ruth Davies Breakdown of academic impact, for papers by John A. Vernon Breakdown of academic impact, for papers by Vakaramoko Diaby Breakdown of academic impact, for papers by Saskia Knies Breakdown of academic impact, for papers by Jui-fen Rachel Lu Breakdown of academic impact, for papers by Hanane Khoury Breakdown of academic impact, for papers by Donna Rindress Breakdown of academic impact, for papers by Petra Schnell‐Inderst Breakdown of academic impact, for papers by Chris Henshall
Rankless by CCL
2026